Adaptimmune and TCR2 Therapeutics, two clinical-stage biotechs that have recently cut staff to conserve capital, are coming together in a deal that aligns their cell therapy strategies. The business combination also extends the new…
Continue Reading
GoodRx reported falling revenue for the fourth quarter, but its stock rallied early Wednesday after beating earnings expectations. The company, best known for its drug cost transparency tools, reported $184.1 million in revenue for Q4…
Continue Reading
Hims & Hers Health’s stock price is up Tuesday after the direct-to-consumer virtual care company reported nearly doubling its revenue in 2022.The company posted revenue of $526.9 million for the year compared with $271.9…
Continue Reading
Teladoc Health stock fell Thursday after the virtual care company reported a $13.7 billion net loss, or $84.60 per share, in 2022.That compares with a net loss of $428.8 million, or $2.73 per share,…
Continue Reading
